Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Drugs Made In America Acquisition (DMAA) Return on Capital Employed (2025)

Drugs Made In America Acquisition filings provide 1 years of Return on Capital Employed readings, the most recent being 1.18% for Q4 2025.

  • Quarterly Return on Capital Employed changed N/A to 1.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.18% through Dec 2025, changed N/A year-over-year, with the annual reading at 2.35% for FY2025, N/A changed from the prior year.
  • Return on Capital Employed hit 1.18% in Q4 2025 for Drugs Made In America Acquisition.
  • Across five years, Return on Capital Employed topped out at 1.18% in Q4 2025 and bottomed at 1.18% in Q4 2025.